The Venture Codex Logo

The Venture Codex

Kainos

4-6 Upper Crescent, Belfast, Northern Ireland, BT7 1NT, United Kingdom

Overview

Kainos Software Limited is a privately held software company headquartered in Belfast, Northern Ireland that develops information technology solutions for businesses and organisations particularly in the public, healthcare and financial services sectors. The company also provides consulting and support services. Kainos has offices in the UK, Ireland, Poland and the U.S., and provides services to its customers across Europe, the Middle East, Africa and North America. Kainos is one of Workday’s main implementation partners for the Workday SaaS product, and have developed Kainos Smart, an automated testing tool for Workday implementations. In the UK, Kainos provide an electronic medical record product for the digitisation of patient notes in the NHS called Evolve. The company also has a long-standing partnership with Autonomy delivering projects to organisations in Europe and Africa. Kainos has been a Microsoft Gold Certified Partner for more than 10 years, and was one of Microsoft's first Gold partners. Today, Kainos is one of Northern Ireland's largest high-tech companies, and one of the top companies in the UK and Ireland.

Total investments
2
Lead investments
0
Investments · 12mo
0
Active investors
0

Sector focus

  • Consulting
  • Financial Services
  • Health Care
  • Information Technology
  • Software
Visit website

Investment portfolio

  • Cirdan

    Participated · Equity · Feb 2016

    Cirdan develops software and imaging solutions for pathology and laboratory diagnostics, including its flagship ULTRA LIS, a next-generation Laboratory Information System that scales from single-site labs to large multi-site laboratories. The company’s products aim to streamline operations, expedite disease diagnosis, and improve patient outcomes and healthcare efficiency. Cirdan’s solutions are deployed in over 200 clinical laboratories and hospitals across 20 countries and six continents. Headquartered in the UK with offices in Canada and Australia, the company was founded in 2010 in Lisburn, Ireland by Dr. Hugh Cormican and Stephen Dunniece. Cirdan plans to use new funding to accelerate delivery capabilities, expand its specialist team, enhance its product offerings, scale operations, and push further global expansion into new markets. Cirdan Imaging provides diagnostic digital health and imaging solutions designed to enhance and speed up patient clinical pathways and pathology laboratory work. Its platform includes specimen imaging solutions, patient and clinician apps, and a laboratory information system that collects critical information in a lean and fast way to reduce diagnostic time and surface new healthcare insights. The platform integrates with digital pathology and AI and is shown to improve efficiency, agility, control, and visibility in labs. Headquartered in the UK with offices in North America and Australia, the company serves clients in over 150 laboratories and hospitals across 20 countries and six continents. Cirdan is experiencing a period of rapid growth and intends to continue expanding with new innovative products and entry into new international markets. The company is led by Stephen Dunniece. Cirdan Imaging develops imaging and informatics technology aimed at accelerating and enhancing medical diagnosis. Its product portfolio includes the ULTRA laboratory information system (ULTRA LIS) and a suite of medical imaging systems. The company was established in 2010 and has additional offices in Canada and Australia. Cirdan employs 32 people and reports a multi‑million pound annual turnover. Growth has been driven in part by a 2013 acquisition of part of GE Healthcare’s business, which provided access to a blue‑chip global customer base. The company plans to use recent funding to strengthen ULTRA LIS, capitalize on a partnership with Kainos, scale operations, enter new markets and increase export sales. Cirdan Imaging develops, manufactures and supplies innovative medical imaging technology used in the diagnosis and management of disease. The company designs and distributes novel medical diagnostic solutions to healthcare customers. It was established in 2010 by CEO Hugh Cormican and CTO Stephen Dunniece and is based in Lisburn, Northern Ireland. Cirdan has been supported by Invest Northern Ireland through Co-Fund NI and QUBIS. Its customer base includes blue-chip companies in the UK, US, Canada, Australia and the Middle East. The company intends to use the recent investment to continue to expand operations.

  • SpeechStorm

    Participated · Equity · Jun 2010

    SpeechStorm provides interactive voice response (IVR) application software that combines speech, touchtone, SMS and video to automate customer service. Its flagship Dynamic IVR platform supports both SaaS and on-premise deployments, and the company plans to launch the latest version this summer. SpeechStorm was first established as a business unit within Kainos in 2007. The company is headquartered in Belfast and also has staff in Dublin and London. SpeechStorm employs 24 people. Customers have included Eircom, Allied Irish Bank, Comet PLC and Etisalat.

Team

No current team members are available.